Cossu F, Fodde M, Ledda P, Pisano G, Rombi G P, Scintu F, Tuveri A
Minerva Med. 1984 Oct 20;75(40):2373-80.
The prognostic value of CEA for the purposes of postoperative monitoring assessed in 45 patients with cancer of the colon and rectum. Values were obtained 1-36 months after surgery in all operable cases. Means were also evaluated statistically at various follow-up times. In patients who relapsed, values stayed significantly higher for up to 6 months after surgery than in those who did not. Cockran's method showed that the prognostic significance of this difference 6 months after surgery was p less than 0.05.
在45例结肠癌和直肠癌患者中评估了癌胚抗原(CEA)用于术后监测的预后价值。在所有可手术病例中,于术后1 - 36个月获取相关数值。还对不同随访时间的均值进行了统计学评估。复发患者术后长达6个月的数值显著高于未复发患者。 Cochr an方法显示,术后6个月这种差异的预后意义为p小于0.05。